122 related articles for article (PubMed ID: 10496054)
41. Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome?
La Marca A; Pati M; Giulini S; Levratti P; Caretto S; Volpe A
Gynecol Endocrinol; 2005 Nov; 21(5):292-4. PubMed ID: 16373249
[TBL] [Abstract][Full Text] [Related]
42. The J-Tip Needle-Free Injection System in controlled ovarian hyperstimulation in in vitro fertilization: a pilot study.
Lavery SA; El-Shawarby SA; Turner C; Trew G
Fertil Steril; 2008 Nov; 90(5):1969-72. PubMed ID: 18166182
[TBL] [Abstract][Full Text] [Related]
43. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial.
De Placido G; Alviggi C; Perino A; Strina I; Lisi F; Fasolino A; De Palo R; Ranieri A; Colacurci N; Mollo A;
Hum Reprod; 2005 Feb; 20(2):390-6. PubMed ID: 15576390
[TBL] [Abstract][Full Text] [Related]
44. Modified natural-cycle in vitro fertilization should be considered as the first approach in young poor responders.
Kadoch IJ; Phillips SJ; Bissonnette F
Fertil Steril; 2011 Nov; 96(5):1066-8. PubMed ID: 22036050
[TBL] [Abstract][Full Text] [Related]
45. Detection of a procoagulable state during controlled ovarian hyperstimulation for in vitro fertilization with global assays of haemostasis.
Westerlund E; Henriksson P; Wallén H; Hovatta O; Wallberg KR; Antovic A
Thromb Res; 2012 Oct; 130(4):649-53. PubMed ID: 22154245
[TBL] [Abstract][Full Text] [Related]
46. Correlation between steroid hormonal levels and cardiac function in women during controlled ovarian hyperstimulation.
Li Y; Sun X; Zang L; Zhang Q; Li J; Zou S
Endocrine; 2013 Dec; 44(3):784-9. PubMed ID: 23576024
[TBL] [Abstract][Full Text] [Related]
47. Controlled ovarian hyperstimulation: are we monitoring the appropriate sex-steroid hormones?
Orvieto R; Hod E; Volodarsky M; Homburg R; Rabinson J; Meltcer S
Fertil Steril; 2008 May; 89(5):1269-1272. PubMed ID: 17658530
[TBL] [Abstract][Full Text] [Related]
48. [Evaluation of ovarian response in ovulation induction].
Anshina MB; Zdanovskiĭ VM; Kechiian KN; Solomatina EV; Vartikian KS
Akush Ginekol (Mosk); 1991 Mar; (3):50-3. PubMed ID: 2058777
[TBL] [Abstract][Full Text] [Related]
49. Successful ovarian superovulation for in vitro fertilization in a patient with an undiagnosed intrauterine pregnancy.
Lessing JB; Kogosowski A; Amit A; Yovel I; Barak Y; David MP; Peyser MR
J In Vitro Fert Embryo Transf; 1991 Aug; 8(4):237-40. PubMed ID: 1753174
[No Abstract] [Full Text] [Related]
50. Evidence-based management of poor ovarian response.
Venetis CA; Kolibianakis EM; Tarlatzi TB; Tarlatzis BC
Ann N Y Acad Sci; 2010 Sep; 1205():199-206. PubMed ID: 20840273
[TBL] [Abstract][Full Text] [Related]
51. In vitro fertilization as an out-patient procedure.
Venezia R; Comparetto G; Gullo D; Cefalù E; Guastella G; Prapas N; Falcone G; Gabrieli M; Cittadini E
Acta Eur Fertil; 1985; 16(4):289-92. PubMed ID: 3907241
[TBL] [Abstract][Full Text] [Related]
52. The use of controlled ovarian hyperstimulation (COH) in clinical in vitro fertilization: the role of Georgeanna Seegar Jones.
Jones HW
Fertil Steril; 2008 Nov; 90(5):e1-3. PubMed ID: 17905235
[TBL] [Abstract][Full Text] [Related]
53. Poor responders to controlled ovarian hyperstimulation for in vitro fertilisation (IVF).
Kamble L; Gudi A; Shah A; Homburg R
Hum Fertil (Camb); 2011 Dec; 14(4):230-45. PubMed ID: 21970738
[TBL] [Abstract][Full Text] [Related]
54. Cross-over trial of superovulation protocols from two major in vitro fertilization centers.
Rogers P; Molloy D; Healy D; McBain J; Howlett D; Bourne H; Thomas A; Wood C; Johnston I; Trounson A
Fertil Steril; 1986 Sep; 46(3):424-31. PubMed ID: 3091407
[TBL] [Abstract][Full Text] [Related]
55. Treatments for inducing superovulation and the endocrine aspects of cycle diagnostics in connection with the in vitro fertilization program.
Bognár Z
Acta Physiol Hung; 1989; 74(3-4):341-9. PubMed ID: 2701150
[TBL] [Abstract][Full Text] [Related]
56. Initial experience with in vitro fertilization in New Jersey.
Kemmann E; Colburn D; Pasquale S; Nosher J; Brandeis VT; Delisi AM; Shelden RM
J Med Soc N J; 1984 Oct; 81(10):849-54. PubMed ID: 6594524
[No Abstract] [Full Text] [Related]
57. [Ovulation stimulation. Use and "abuse"].
Nilsson L; Bergh T; Jeppson S; Wramsby H
Lakartidningen; 1995 Feb; 92(7):635-7. PubMed ID: 7861857
[No Abstract] [Full Text] [Related]
58. [Organization of ambulatory sterility treatment using in-vitro fertilization and embryo transfer in the USSR].
Reich N; Finogenowa E; Leonow B; Lukin W
Zentralbl Gynakol; 1991; 113(7):367-9. PubMed ID: 2063630
[No Abstract] [Full Text] [Related]
59. Increase in serum leptin concentrations in women undergoing controlled ovarian hyperstimulation for assisted reproduction.
Strowitzki T; Kellerer M; Capp E; Häring HU
Gynecol Endocrinol; 1998 Jun; 12(3):167-9. PubMed ID: 9675562
[TBL] [Abstract][Full Text] [Related]
60. [Changes in blood pressure and heart rate by an increase in serum estradiol in women undergoing controlled ovarian hyperstimulation].
Tomczy R; Paluch K; Gałuszka-Bednarczyk A; Milewicz T; Janeczko J; Klocek M
Przegl Lek; 2015; 72(4):174-7. PubMed ID: 26455014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
